MemScreen vs Guide Prescrire
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
MemScreen
This medical app assists healthcare professionals in screening for verbal episodic memory issues. It offers a self-administered test for individuals with cognitive concerns, providing scores that may indicate the need for further evaluation. Results are anonymous, with a history feature for physician review.
- Verbal episodic memory screening
- Self-administered test
- Physician supervision required
- Anonymous testing
- History of previous sessions
- Score interpretation guidance
Read full descriptionHide full description
MemScreen is an application designed for healthcare professionals to assess memory in individuals with cognitive complaints. It provides a first-line screening test for verbal episodic memory. The test is self-administered by the individual, under the supervision of a physician or healthcare professional. A total score ≤ 29/34 or a memory score ≤ 9/12 may warrant further evaluation, depending on the clinical context. A normal test result does not exclude early-stage memory impairment. This application is not a substitute for a full medical cognitive assessment. Testing is performed anonymously. Physicians can review previous session results in the “History” section. This application was conceived by Prof. Julien Dumurgier and developed by the Cognitive Neurology Center, Lariboisière–Fernand Widal Hospital, AP-HP, Université Paris Cité. More information: https://www.memscreen.com/
Guide Prescrire
This medical decision support tool helps healthcare professionals choose the most effective, safe, and appropriate treatments. It provides updated information organized for easy use in clinical settings. A free discovery mode offers access to practical scenarios.
- Decision support for treatment selection
- Updated medical information
- Organized for clinical use
- Free discovery mode
- Focus on effective and safe treatments
Read full descriptionHide full description
Le Guide Prescrire est un outil d’aide à la décision en situation de 1er recours pour choisir les traitements les plus efficaces, les plus sûrs et les plus adaptés, grâce à une information actualisée et organisée pour être facilement utilisable en situation de soins et de conseil. Ce Guide est inclus dans l’abonnement à Prescrire. Testez ce guide gratuitement grâce au mode découverte qui vous permet d’accéder à quelques situations pratiques (accès possible sans être abonné à Prescrire).
Screenshots
Verdict
The clearest difference is review sentiment: MemScreen at 100% against Guide Prescrire's 50%. MemScreen also leads on update cadence (every 2 months vs every 8 months). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MemScreen ships an update every 2 months, Guide Prescrire every 8 months. The most recent releases landed on November 2, 2026 and November 6, 2026 respectively.
| Parameter | MemScreen | Guide Prescrire |
|---|---|---|
| Price | Free | Free |
| Positive reviews | 100.0% of reviews — better | 50.0% of reviews |
| Update frequency | Every 2 months — better | Every 8 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 14.0 — better | 15.0 |
| Further details — not scored | ||
| Size | 19 MB | 84 MB |
| Age rating | 4+ | 17+ |
| Developer | Julien Dumurgier | Association Mieux Prescrire |
Customer experience
MemScreen
Guide Prescrire
In-app purchases
MemScreen
No in-app purchases
Guide Prescrire
No in-app purchases
Questions
Is MemScreen free?
Is Guide Prescrire free?
Do MemScreen or Guide Prescrire have ads?
Which is updated more often, MemScreen or Guide Prescrire?
Other comparisons















